Detalhe da pesquisa
1.
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors.
J Clin Psychopharmacol
; 42(1): 17-22, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928557